Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-24

FDA Approved: LEVETIRACETAM ER — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM ER from Westminster Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM ER (LEVETIRACETAM)

Snippet

SUPPL AP for LEVETIRACETAM ER (LEVETIRACETAM)